Ibaraki, Japan

Kiyohiko Uchikawa

This inventor holds 1 USPTO granted patent. Top assignee: Eisai Company, Limited. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kiyohiko Uchikawa. Retrieved from https://idiyas.com/inventor/kiyohiko-uchikawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kiyohiko Uchikawa and His Patent on Cephem Derivative Crystals.

Introduction

Kiyohiko Uchikawa is an inventor associated with Ibaraki, Japan. His listed patent work concerns crystals of a cephem derivative, and he is associated with Eisai Company, Limited.

Latest Patents

Uchikawa is credited with 1 patent. The patent, “Cephem Derivative Crystals,” describes crystals of 7β-[(Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetamido]-3-(4-carbamoyl-1-quinuclidinio)methyl-3-cephem-4-carboxylate. It identifies the crystals by characteristic X-ray diffraction intensities at specified d-spacings.

Career Highlights

The available information connects Uchikawa’s patent activity with Eisai Company, Limited. The patent’s focus on crystal characteristics reflects an invention in pharmaceutical chemistry and materials characterization.

Collaborations

Tadashi Sato and Yasuo Ishibashi are listed as Uchikawa’s coworkers. The provided information does not specify their roles in the patent or the nature of their collaboration.

Conclusion

Kiyohiko Uchikawa’s recorded invention concerns the identification of cephem derivative crystals through X-ray diffraction, linking his patent work to pharmaceutical research at Eisai Company, Limited.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…